Clinical Trial Update: Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating Ivonescimab for pleural mesothelioma that has progressed after prior immunotherapy and chemotherapy; the trial is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Mesothelioma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Pleural Mesotheliomas | Phase 2 | Status: RECRUITING